The Graeme Clark Institute for Biomedical Engineering (GCI), The University of Melbourne in partnership with the Melbourne Academic Centre for Health (MACH) and Neurosciences Victoria is inviting submissions for the HealthTech Innovation Challenge for 2018.
The objectives of the HealthTech Innovation Challenge are:
- To promote Science, Technology, Engineering, Mathematics and Medicine (STEMM)-based interdisciplinary research
- To foster the translation of research with applications that will lead to improvements in health outcomes.
- To stimulate collaboration of MACH partner organisations:
- Austin Health
- Bionics Institute
- Centre for Eye Research Australia
- Melbourne Health
- Mercy Health
- Murdoch Childrens Research Institute
- Northern Health
- Olivia Newton-John Cancer Research Institute
- Peter MacCallum Cancer Centre
- St Vincent’s Hospital Melbourne
- St Vincent’s Institute of Medical Research
- Florey Neuroscience Institute
- The Royal Children’s Hospital Melbourne
- The Royal Victorian Eye and Ear Hospital
- The Royal Women’s Hospital Victoria
- The University of Melbourne
- Walter and Eliza Hall Institute of Medical Research
- Western Health
For more information about MACH visit their website: Melbourne Academic Centre for Health
- Tuesday 5 June 2018
Launch date of the HealthTech Innovation Challenge
- Monday 9 July 2018
Application closing date
- Early August 2018
Announcement of the finalists
- Monday 13 August 2018
- Early September 2018
Project start date
- Sunday 31 March 2019
Project progress report due
- Saturday 31 August 2019
Project progress report due
Four projects in the HealthTech Innovation Challenge will each receive a prize of $20,000 in cash to be applied towards the further development of their project
See the section on Application Process to accept the Competition Terms.
The submissions will be assessed against the following judging criteria.
The project demonstrates innovative inter-disciplinary research that has significant potential for future funding by granting bodies and/or industry.
Privacy collection notice
The Graeme Clark Institute for Biomedical Engineering (‘GCI’), The University of Melbourne is running the HealthTech Innovation Challenge (‘The Challenge’) that will be opened to partners in the Melbourne Academic Centre for Health (‘MACH’).
The GCI will be collecting personal information comprising name, phone number, email address and host institution of the Lead and Partner Investigators for The Challenge. Information provided will be used solely for The Challenge.
Your personal information can be removed if you no longer wish to participate in The Challenge. To request that your information be removed, please contact:
Dr Jia-Yee Lee,
Director, Industry Engagement,
Graeme Clark Institute for Biomedical Engineering
Telephone: +61 3 83444923
The information will only be accessed by authorised staff for the purpose for which it was collected, and will be protected against unauthorised access and use.
The lead investigators (LI) and partner investigators (PI) must ensure that the GCI contribution and support of the project be appropriately acknowledged in publications and presentations.
The four prizes are sponsored by the Graeme Clark Institute for Biomedical Engineering.
One of the prizes is co-sponsored by Cadmon Advisory.
All enquiries should be made to firstname.lastname@example.org. The Subject line should state “HTIC”.
Lead Investigator (LI)
The LI is an employee of one of the MACH partner organisations and takes responsibility for project reporting and delivery in accordance with the Guidelines and Competition Terms. It is preferable that the LI should have an appointment with a Faculty at The University of Melbourne.
Partner investigator (PI)
A partner investigator must be an employee of an organisation from academia, hospital or industry.
Australian or overseas companies (including small-to-medium sized enterprises) or not-for-profit organisations.
Technology Readiness Levels
Technology readiness level (TRL) is an approach to assess the technology maturity and progress of the research activity. The TRL is defined below (U.S. Department of Defense, Technology Readiness Assessment Guidance, April 2011).
|TRL 1||Basic Research: Initial scientific research has been conducted. Principles are qualitatively postulated and observed. Focus is on new discovery rather than applications.|
|TRL 2||Applied Research: Initial practical applications are identified. Potential of material or process to solve a problem, satisfy a need, or find application is confirmed.|
|TRL 3||Critical Function or Proof of Concept Established: Applied research advances and early stage development begins. Studies and laboratory measurements validate analytical predictions of separate elements of the technology.|
|TRL 4||Lab Testing/Validation of Alpha Prototype Component/Process: Design, development and lab testing of components/processes. Results provide evidence that performance targets may be attainable based on projected or modelled systems.|
|TRL 5||Laboratory Testing of Integrated/Semi-Integrated System: System Component and/or process validation is achieved in a relevant environment.|
|TRL 6||Prototype System Verified: System/process prototype demonstration in an operational environment (beta prototype system level).|
|TRL 7||Integrated Pilot System Demonstrated: System/process prototype demonstration in an operational environment (integrated pilot system level).|
|TRL 8||System Incorporated in Commercial Design: Actual system/process completed and qualified through test and demonstration (pre-commercial demonstration).|
|TRL 9||System Proven and Ready for Full Commercial Deployment: Actual system proven through successful operations in operating environment, and ready for full commercial deployment.|